Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis
暂无分享,去创建一个
M. Metra | A. Moreo | D. Farina | E. Vizzardi | A. Bonelli | M. Adamo | M. Pagnesi | R. Inciardi | G. Arabia | D. Tomasoni | C. Lombardi | A. Cersosimo | M. Pagnesi
[1] M. Emdin,et al. N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T hold diagnostic value in cardiac amyloidosis , 2023 .
[2] A. Cohen-Solal,et al. NT-proBNP and High-Sensitivity Troponin T Hold Diagnostic Value in Cardiac Amyloidosis. , 2022, European journal of heart failure.
[3] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). , 2022, Revista espanola de cardiologia.
[4] M. Emdin,et al. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies , 2022, European journal of heart failure.
[5] G. Parati,et al. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey , 2022, European journal of heart failure.
[6] Germany,et al. Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). , 2022, European heart journal.
[7] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[8] M. Henein,et al. Aortic Valve Stenosis and Cardiac Amyloidosis: A Misleading Association , 2021, Journal of clinical medicine.
[9] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[10] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[11] D. Carrié,et al. Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis. , 2021, Circulation journal : official journal of the Japanese Circulation Society.
[12] U. Eriksson,et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. , 2021, European heart journal.
[13] U. Eriksson,et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases , 2021, European journal of heart failure.
[14] M. Emdin,et al. A simple echocardiographic score to rule out cardiac amyloidosis , 2020, European journal of clinical investigation.
[15] T. Tan,et al. The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update , 2020, Frontiers in Cardiovascular Medicine.
[16] E. Klotz,et al. Identifying Cardiac Amyloid in Aortic Stenosis , 2020, JACC. Cardiovascular imaging.
[17] C. Di Mario,et al. Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it. , 2020, Cardiovascular revascularization medicine : including molecular interventions.
[18] E. Klotz,et al. DPD Quantification in Cardiac Amyloidosis , 2020, JACC. Cardiovascular imaging.
[19] C. Rapezzi,et al. Multimodality imaging in cardiac amyloidosis: a primer for cardiologists. , 2020, European heart journal cardiovascular Imaging.
[20] A. Masri,et al. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis , 2020, European journal of heart failure.
[21] C. Loewe,et al. Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome , 2020, European journal of heart failure.
[22] J. Moon,et al. Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients , 2020 .
[23] G. Pontone,et al. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. , 2019, JACC. Cardiovascular imaging.
[24] C. Autore,et al. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. , 2019, JACC. Cardiovascular imaging.
[25] Z. Prohászka,et al. Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance , 2019, Cardiovascular Ultrasound.
[26] P. Pibarot,et al. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[27] A. Aidietis,et al. Transthyretin cardiac amyloidosis in aortic stenosis: prevalence, diagnostic challenges and clinical implications. , 2019, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[28] P. Elliott,et al. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta‐analysis , 2019, ESC heart failure.
[29] C. Rapezzi,et al. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. , 2019, Circulation. Heart failure.
[30] M. Dweck,et al. Why and How to Measure Aortic Valve Calcification in Patients With Aortic Stenosis. , 2019, JACC. Cardiovascular imaging.
[31] Y. Yamashita,et al. Myocardial Late Iodine Enhancement and Extracellular Volume Quantification with Dual-Layer Spectral Detector Dual-Energy Cardiac CT. , 2019, Radiology. Cardiothoracic imaging.
[32] M. Desai,et al. Distribution and Prognostic Significance of Left Ventricular Global Longitudinal Strain in Asymptomatic Significant Aortic Stenosis: An Individual Participant Data Meta-Analysis. , 2019, JACC. Cardiovascular imaging.
[33] Sanjay K. Prasad,et al. Myocardial Scar and Mortality in Severe Aortic Stenosis , 2018, Circulation.
[34] J. Moon,et al. Cardiac amyloidosis in aortic stenosis: The tip of the iceberg. , 2018, The Journal of thoracic and cardiovascular surgery.
[35] M. Maurer,et al. Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis. , 2018, Journal of cardiac failure.
[36] M. Galderisi,et al. Echocardiographic advances in hypertrophic cardiomyopathy: Three‐dimensional and strain imaging echocardiography , 2018, Echocardiography.
[37] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[38] A. Luciani,et al. Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study , 2018, European Radiology.
[39] D. Forman,et al. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis , 2017, Journal of Cardiovascular Magnetic Resonance.
[40] M. Leon,et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement , 2017, European heart journal.
[41] B. Wintersperger,et al. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics , 2017, Journal of Cardiovascular Magnetic Resonance.
[42] P. Kellman,et al. Magnetic Resonance in Transthyretin Cardiac Amyloidosis. , 2017, Journal of the American College of Cardiology.
[43] S. Punwani,et al. Automatic quantification of the myocardial extracellular volume by cardiac computed tomography: Synthetic ECV by CCT. , 2017, Journal of cardiovascular computed tomography.
[44] D. Pennell,et al. Midwall Fibrosis and 5-Year Outcome in Moderate and Severe Aortic Stenosis. , 2017, Journal of the American College of Cardiology.
[45] D. Bergqvist,et al. A population-based autopsy study , 2017 .
[46] C. Tribouilloy,et al. Usefulness of 3-Tesla cardiac magnetic resonance imaging in the assessment of aortic stenosis severity in routine clinical practice. , 2016, Archives of cardiovascular diseases.
[47] S. K. White,et al. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. , 2016, Circulation. Cardiovascular imaging.
[48] G. Dattilo,et al. Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy - Comparative Strain Imaging Study. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[49] W. Jaber,et al. Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis. , 2016, JACC. Cardiovascular imaging.
[50] William Y S Wang,et al. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study , 2016, The Journal of Nuclear Medicine.
[51] S. Heymans,et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.
[52] James C Moon,et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.
[53] C. Rapezzi,et al. Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis. , 2016, JACC. Cardiovascular imaging.
[54] J. Dubois-Randé,et al. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? , 2016, European Heart Journal.
[55] V. S.. Misleading association , 2016, BDJ.
[56] S. Punwani,et al. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.
[57] P. Kellman,et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.
[58] R. Falk,et al. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study , 2015, Circulation. Cardiovascular imaging.
[59] J. Moon,et al. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study. , 2015, Radiology.
[60] A. Luciani,et al. Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study , 2015, European Radiology.
[61] Michael J.A. Williams,et al. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. , 2014, Journal of the American College of Cardiology.
[62] B. Hazenberg,et al. Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[63] L. Anderson,et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. , 2014, JACC. Cardiovascular imaging.
[64] M. Bursztyn. Impact on Prognosis , 2014 .
[65] B. Bijnens,et al. Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis From Other Causes of Concentric Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.
[66] A. Bogers,et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. , 2013, Journal of the American College of Cardiology.
[67] M. Lubberink,et al. In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET , 2013, The Journal of Nuclear Medicine.
[68] G. Nguyen. Tip of the iceberg? , 2012, Gut microbes.
[69] James D. Thomas,et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.
[70] E. V. van Beek,et al. Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis , 2012, Circulation.
[71] F. Salvi,et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. , 2011, JACC. Cardiovascular imaging.
[72] P. Limburg,et al. Diagnostic performance of transthyretin measurement in fat tissue of patients with ATTR amyloidosis , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[73] C. Rochitte,et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. , 2010, Journal of the American College of Cardiology.
[74] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[75] A. Singleton,et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2‐macroglobulin and tau: A population‐based autopsy study , 2008, Annals of medicine.
[76] F. Salvi,et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.
[77] R. Falk,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis , 2005, American journal of hematology.
[78] It Istituto Superiore di Sanit,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from th 10th International Symposium on Amyloid an Amyloidosis, Tours, France, 18-22 April 2004 , 2005 .
[79] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[80] R A Kyle,et al. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. , 1983, The American journal of medicine.
[81] DPD Quanti fi cation in Cardiac Amyloidosis A Novel Imaging Biomarker , 2022 .